Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Open Label Study for the Use of Transcranial Ultrasound for Treatment of Age-Related Frailty
Authors not listed
Neurological Associates of West Los Angeles · 2023
Abstract
The purpose of this Phase I open label study is to evaluate longer term tolerability and potential effectiveness of transcranial ultrasound in people with age-related frailty.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
Anonymous. (2023). Open Label Study for the Use of Transcranial Ultrasound for Treatment of Age-Related Frailty. <em>Neurological Associates of West Los Angeles</em>. https://clinicaltrials.gov/study/NCT04770350
Vancouver
Anonymous. Open Label Study for the Use of Transcranial Ultrasound for Treatment of Age-Related Frailty. Neurological Associates of West Los Angeles. 2023.
BibTeX
@misc{anon2023OpenLa,
title = {Open Label Study for the Use of Transcranial Ultrasound for Treatment of Age-Related Frailty},
author = {Anonymous},
journal = {Neurological Associates of West Los Angeles},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neurological Associates of West Los Angeles 2021
Open access · US-GOV
Open Label Study for the Use of Plasmapheresis for Treatment of Age-Related Frailty
American Journal of Ophthalmology 2007
Citation only
Ranibizumab According to Need: A Treatment for Age-related Macular Degeneration
Myrexis Inc. 2006
Open access · US-GOV
Open Label Study of the Effect of Daily Treatment With MPC-7869 in Subjects With Dementia of the Alzheimer's Type
Fondazione EMN Italy Onlus 2006
Open access · US-GOV
A PHASE III, MULTI-CENTER, RANDOMIZED OPEN LABEL STUDY OF VELCADE, MELPHALAN, PREDNISONE AND THALIDOMIDE (V-MPT) Versus VELCADE, MELPHALAN, PREDNISONE (V-MP) IN ELDERLY UNTREATED MULTIPLE MYELOMA PATIENTS
Ophthalmology 2006
Open access · OA
Frailty and Age-Related Cataract
Meridigen Biotech Co., Ltd. 2021
Open access · US-GOV